对于不补偿性心力衰竭的医院内所规定的摄入量:系统性审查和元分析
Htun Ja Mai1, Ghid Kanaan1, Sebhat Erqou2,3,4
1Center for Evidence Synthesis in Health, Brown University, Providence, Rhode Island, USA.
Journal of hospital medicine
|June 1, 2025
概括
补充剂与利尿剂可以改善功能,并促进急性失补心力衰竭患者的体重减轻. 这种方法也可能缩短住院时间,为标准的限制提供了潜在的替代方案.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内部医学 内部医学
背景情况:
- 急性不补偿性心力衰竭 (ADHF) 的标准治疗包括限制饮食中的.
- 补充剂与利尿剂相结合被探索为一种新的住院ADHF管理策略.
研究的目的:
- 在住院的ADHF患者中,系统地审查处方口服和/或静脉补充剂与利尿剂的疗效.
主要方法:
- 在多个数据库 (Medline,Embase等) 中进行全面的搜索. 调查时间为2024年9月24日.
- 包括随机对照试验 (RCT) 和非随机比较研究 (NRCS).
- 对至少三项类似研究的结果进行了元分析,使用GRADE方法来确定证据的强度.
主要成果:
- 补充与furosemide显著降低了血清肌,大脑 natriuretic 和患者的体重.
- 观察到住院时间的显著减少.
- 对于N-终端pro b型性尿素没有发现显著差异;对于死亡率和再接收结果的证据不足.
结论:
- 与利尿剂一起补充显示出改善功能的潜在益处.
- 这种治疗方法可能有助于减肥,并减少ADHF患者住院时间.
- 需要进一步的研究来评估对死亡率和再接收率的影响.
相关概念视频
Heart Failure V: Medical Management
223
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
223
Heart Failure VI: Adjunct Therapies
263
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
263
Heart Failure Drugs: Diuretics
812
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
812
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
943
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
943
Mitral Regurgitation IV: Nursing Management
312
Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
312
Heart Failure VII: Nursing Interventions
425
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
425
